Generic Name
Bisoprolol fumarate
Brand Names
Concor
Zebeta (in some regions)
Emcor
Generic formulations widely available globally
Drug Class
Beta-1 selective adrenergic receptor blocker (Cardioselective beta-blocker)
Antihypertensive agent
Antianginal agent
Mechanism of Action
Bisoprolol selectively blocks beta-1 adrenergic receptors in the heart, reducing the effects of adrenaline and noradrenaline
This leads to decreased heart rate, myocardial contractility, and cardiac output
It also reduces renin secretion from the kidneys, contributing to a drop in blood pressure
Because of its cardioselectivity, it has less effect on beta-2 receptors found in bronchial and vascular smooth muscle, making it safer than non-selective beta-blockers in patients with mild asthma or COPD
Its effects are dose-dependent; cardioselectivity may decrease at higher doses
Indications
Approved Uses
Hypertension (high blood pressure)
Chronic stable angina pectoris
Chronic heart failure (stable, with reduced ejection fraction, usually in combination with ACE inhibitors, diuretics, and aldosterone antagonists)
Off-label/Clinical Practice Uses
Atrial fibrillation (rate control)
Supraventricular tachycardia
Migraine prophylaxis (rarely)
Anxiety-related tachycardia
Prevention of myocardial infarction recurrence
Post-myocardial infarction beta-blocker therapy
Management of hyperthyroidism symptoms
Dosing and Administration
Hypertension/Angina (Adults)
Initial dose: 5 mg once daily
May be increased to 10 mg once daily
Maximum dose: 20 mg once daily
Chronic Heart Failure (Adults)
Start at 1.25 mg once daily
Titrate slowly every 1–2 weeks if tolerated:
Next doses: 2.5 mg → 3.75 mg → 5 mg → 7.5 mg → 10 mg
Target maintenance dose: 10 mg once daily
Renal Impairment
For severe renal dysfunction (creatinine clearance <40 mL/min), maximum dose should not exceed 10 mg/day
Dose adjustment or close monitoring may be required
Hepatic Impairment
Use cautiously in moderate to severe hepatic impairment
No routine dose adjustment, but start at lower end of dosing range and monitor
Elderly
No specific dosage adjustment, but initiate therapy at the lower dose range
Monitor for bradycardia, hypotension, and fatigue
Pediatric Use
Safety and efficacy not established in children
Not recommended unless under specialist advice
Contraindications
Hypersensitivity to bisoprolol or any component
Severe bradycardia
Second- or third-degree AV block without pacemaker
Sick sinus syndrome
Cardiogenic shock
Acute decompensated heart failure
Severe peripheral arterial disease with critical limb ischemia
Severe asthma or bronchospasm
Precautions
Avoid abrupt discontinuation—gradually taper to avoid rebound tachycardia, hypertension, or angina exacerbation
Use caution in patients with mild/moderate bronchospastic disease
May mask signs of hypoglycemia in diabetic patients (e.g. tachycardia)
May mask signs of hyperthyroidism
May worsen symptoms in patients with peripheral vascular disease or Raynaud's phenomenon
Monitor patients with history of depression
Avoid in untreated pheochromocytoma unless alpha-blockade established
Adverse Effects
Common
Bradycardia
Fatigue
Dizziness
Hypotension
Headache
Cold extremities
Nausea
Diarrhea or constipation
Sleep disturbances or vivid dreams
Less Common
Depression
Impotence or reduced libido
Shortness of breath in predisposed patients
Weight gain (in heart failure patients)
Atrioventricular block (dose-dependent)
Rare but Serious
Exacerbation of heart failure
Bronchospasm (in asthma or COPD)
Severe bradycardia or hypotension
Masked hypoglycemia in diabetic patients
Liver enzyme elevations
Hypersensitivity reactions (rash, pruritus)
Pregnancy and Lactation
Pregnancy
Category C (may vary by country)
Bisoprolol crosses the placenta and may cause fetal bradycardia, hypoglycemia, or growth restriction
Use only when clearly indicated and benefits outweigh risks
Close fetal monitoring recommended if used
Lactation
Excreted in small amounts in breast milk
Use with caution in breastfeeding mothers
Monitor infant for bradycardia and hypoglycemia
Use in Special Populations
Heart Failure Patients
Initiate at very low doses
Titrate slowly over weeks with close monitoring
Use only in stable CHF
Renal and Hepatic Impairment
Dose reduction may be required
Monitor closely for accumulation effects
Elderly Patients
Greater sensitivity to bradycardia and hypotension
Start low and monitor regularly
Diabetic Patients
May mask adrenergic symptoms of hypoglycemia
Use with regular glucose monitoring
Drug Interactions
Calcium Channel Blockers (e.g. verapamil, diltiazem)
Additive effects on AV conduction and myocardial depression
Avoid combination or monitor ECG closely
Clonidine
Risk of rebound hypertension if either drug is withdrawn abruptly
Discontinue beta-blocker several days before stopping clonidine
Antiarrhythmics (e.g. amiodarone, digoxin)
Increased risk of bradycardia and AV block
Monitor ECG and heart rate
NSAIDs
May reduce antihypertensive efficacy of bisoprolol
Monitor blood pressure
Insulin and oral hypoglycemics
May mask hypoglycemia symptoms
Monitor glucose closely
Anesthesia agents
May enhance myocardial depression and hypotension
Inform anesthetist of beta-blocker use
Monitoring Parameters
Heart rate (avoid HR <50 bpm)
Blood pressure
Signs of worsening heart failure
Electrocardiogram in high-risk patients
Serum glucose (in diabetics)
Renal and liver function in prolonged use
Patient Counseling Points
Take the medication at the same time each day
Do not stop taking bisoprolol abruptly
Inform provider of fatigue, dizziness, fainting, or breathing difficulty
Check your pulse; report very slow heartbeat
May take a few weeks for full effect
Rise slowly to avoid lightheadedness
Avoid alcohol and excessive heat exposure
Inform dentist/surgeon of bisoprolol use
If diabetic, monitor glucose more frequently
Report cold hands/feet, mood changes, or new shortness of breath
Storage
Store at room temperature
Protect from moisture and heat
Keep in original container with tight cap
No comments:
Post a Comment